Literature DB >> 9877485

Costs of asthma according to the degree of severity.

J Serra-Batlles1, V Plaza, E Morejón, A Comella, J Brugués.   

Abstract

An increase in asthma-related morbidity and mortality has been reported recently, resulting in a substantial increase in the economic impact of this condition. Little information is available relating to the costs of asthma depending on the degree of severity of the disease. Total, direct and indirect costs generated by asthma patients who sought medical care for asthma control over a one-year period in a northern area of Spain were determined. Data were obtained from the patients themselves and severity of illness was classified into mild, moderate and severe according to the International Consensus Report on Diagnosis and Treatment of Asthma, 1992. The average total annual asthma-derived cost was estimated at US$2,879 per patient, with averages of US$1,336 in mildly asthmatic patients, US$2,407 in moderate asthma and US$6,393 in severe asthma. At all levels of severity, indirect costs were twice as high as direct costs, and at the same degree of severity, direct costs due to medication and hospitalization were higher among females than males. A minority of severe asthmatics incurred some 41% of the total costs. The cost of asthma was surprisingly high and varied substantially depending on the degree of severity of the disease. Further knowledge of the costs of asthma across various levels of severity will contribute to a better characterization of optimal intervention strategies for asthma care.

Entities:  

Mesh:

Year:  1998        PMID: 9877485     DOI: 10.1183/09031936.98.12061322

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  63 in total

1.  Strategies for molecular classification of asthma using bipartite network analysis of cytokine expression.

Authors:  Regina R Pillai; Rohit Divekar; Allan Brasier; Suresh Bhavnani; William J Calhoun
Journal:  Curr Allergy Asthma Rep       Date:  2012-10       Impact factor: 4.806

Review 2.  The Role of Type 2 Inflammation in the Pathogenesis of Asthma Exacerbations.

Authors:  Eleanor M Dunican; John V Fahy
Journal:  Ann Am Thorac Soc       Date:  2015-11

Review 3.  Cost-of-illness studies : a review of current methods.

Authors:  Ebere Akobundu; Jing Ju; Lisa Blatt; C Daniel Mullins
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

4.  Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program.

Authors:  Wendy C Moore; Eugene R Bleecker; Douglas Curran-Everett; Serpil C Erzurum; Bill T Ameredes; Leonard Bacharier; William J Calhoun; Mario Castro; Kian Fan Chung; Melissa P Clark; Raed A Dweik; Anne M Fitzpatrick; Benjamin Gaston; Mark Hew; Iftikhar Hussain; Nizar N Jarjour; Elliot Israel; Bruce D Levy; James R Murphy; Stephen P Peters; W Gerald Teague; Deborah A Meyers; William W Busse; Sally E Wenzel
Journal:  J Allergy Clin Immunol       Date:  2007-02       Impact factor: 10.793

5.  Diminished lipoxin biosynthesis in severe asthma.

Authors:  Bruce D Levy; Caroline Bonnans; Eric S Silverman; Lyle J Palmer; Gautham Marigowda; Elliot Israel
Journal:  Am J Respir Crit Care Med       Date:  2005-06-16       Impact factor: 21.405

6.  Molecular phenotyping of severe asthma using pattern recognition of bronchoalveolar lavage-derived cytokines.

Authors:  Allan R Brasier; Sundar Victor; Gary Boetticher; Hyunsu Ju; Chang Lee; Eugene R Bleecker; Mario Castro; William W Busse; William J Calhoun
Journal:  J Allergy Clin Immunol       Date:  2008-01       Impact factor: 10.793

7.  Health-care cost reduction resulting from primary-care allergy testing in children in Italy.

Authors:  Niklas Zethraeus; Carl Johan Petersson; Massimiliano Dozzi; Magnus P Borres; Giulio Vignati; Alessandro Fiocchi
Journal:  Ital J Pediatr       Date:  2010-09-13       Impact factor: 2.638

Review 8.  Insights into interventions in managing COPD patients: lessons from the TORCH and UPLIFT studies.

Authors:  Marc Miravitlles; Antonio Anzueto
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2009-05-07

Review 9.  Economic burden of asthma: a systematic review.

Authors:  Katayoun Bahadori; Mary M Doyle-Waters; Carlo Marra; Larry Lynd; Kadria Alasaly; John Swiston; J Mark FitzGerald
Journal:  BMC Pulm Med       Date:  2009-05-19       Impact factor: 3.317

10.  Comorbidities in severe asthma: frequency of rhinitis, nasal polyposis, gastroesophageal reflux disease, vocal cord dysfunction and bronchiectasis.

Authors:  Carla Bisaccioni; Marcelo Vivolo Aun; Edcarlos Cajuela; Jorge Kalil; Rosana Câmara Agondi; Pedro Giavina-Bianchi
Journal:  Clinics (Sao Paulo)       Date:  2009       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.